Ticagrelor versus clopidogrel in acute coronary syndromes

N Engl J Med. 2009 Dec 10;361(24):2386; author reply 2387-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / mortality
  • Adenosine / adverse effects
  • Adenosine / analogs & derivatives*
  • Adenosine / therapeutic use
  • Clopidogrel
  • Coronary Artery Bypass / adverse effects*
  • Hemorrhage / chemically induced*
  • Humans
  • Myocardial Infarction / prevention & control
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2 Receptor Antagonists*
  • Stroke / prevention & control
  • Ticagrelor
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2 Receptor Antagonists
  • Clopidogrel
  • Ticagrelor
  • Adenosine
  • Ticlopidine